Malignant Neoplasm of Stomach Completed Phase 2 Trials for Sorafenib (DB00398)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01187212Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment EvaluationTreatment
NCT01158287Sorafenib. ICORG 06-41, V4Treatment